Alkem Laboratories Ltd
NSE :ALKEM BSE :539523 Sector : PharmaceuticalsBuy, Sell or Hold ALKEM? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
24 Dec 5406.30 (-1.38%) | 23 Dec 5481.90 (1.00%) | 20 Dec 5427.50 (-1.21%) | 19 Dec 5494.25 (0.02%) | 18 Dec 5493.25 (1.88%) | 17 Dec 5391.65 (-0.94%) | 16 Dec 5442.80 (1.31%) | 13 Dec 5372.55 (-1.15%) | 12 Dec 5435.25 (-1.00%) | 11 Dec 5489.95 (0.56%) | 10 Dec 5459.45 (-0.46%) | 09 Dec 5484.60 (-0.38%) | 06 Dec 5505.40 (-2.45%) | 05 Dec 5643.95 (-0.51%) | 04 Dec 5672.70 (0.63%) | 03 Dec 5637.35 (-0.97%) | 02 Dec 5692.75 (0.89%) | 29 Nov 5642.45 (3.40%) | 28 Nov 5457.15 (0.13%) | 27 Nov 5449.85 (-0.63%) | 26 Nov 5484.40 (0.11%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Neutral
Moving Averages
5 DMA
Bearish
5460.77
10 DMA
Bearish
5443.98
20 DMA
Bearish
5504.49
50 DMA
Bearish
5686.67
100 DMA
Bearish
5836.15
200 DMA
Bearish
5441.31
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Dec 24, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 5573.05 | 5530.6 | 5435.07 | - | - |
R2 | 5530.6 | 5490.64 | 5425.48 | 5525.68 | - |
R1 | 5468.45 | 5465.96 | 5415.89 | 5458.61 | 5499.53 |
P | 5426 | 5426 | 5426 | 5421.08 | 5441.54 |
S1 | 5363.85 | 5386.04 | 5396.71 | 5354.01 | 5394.93 |
S2 | 5321.4 | 5361.36 | 5387.12 | 5316.48 | - |
S3 | 5259.25 | 5321.4 | 5377.54 | - | - |
Key Metrics
EPS
180.88
P/E
29.91
P/B
5.5
Dividend Yield
0.74%
Market Cap
64,640 Cr.
Face Value
2
Book Value
984.46
ROE
18.72%
EBITDA Growth
886.31 Cr.
Debt/Equity
0.15
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Alkem Laboratories Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | ||
INCOME | 3503.36 | 3417.51 | 3023.99 | 3152.13 | 3549.15 | |
PROFIT | 664.03 | 637.37 | 303.22 | 545.16 | 688.64 | |
EPS | 51.9 | 49.76 | 24.55 | 45.6 | 57.6 |
Alkem Laboratories Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | ||
INCOME | 2696.43 | 2590.25 | 2449.16 | 2606.2 | 2992.16 | |
PROFIT | 646.51 | 546.85 | 335 | 583.25 | 697.58 | |
EPS | 54.07 | 42.17 | 27.18 | 48.78 | 58.34 |
Profit & Loss (Figures in Rs. Crores)
Alkem Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 3958.07 | 5268.99 | 6089.14 | 6611.58 | 7441.25 | 8678.53 | 9432.06 | 11332.32 | 11352.97 | 12964.3 | |
PROFIT | 362.81 | 751.53 | 893.54 | 630.55 | 764.73 | 1126.16 | 1554.57 | 1656.06 | 1073.17 | 1894.42 | |
EPS | 0 | 62.92 | 74.45 | 53.4 | 64.71 | 96.14 | 135.32 | 140.55 | 84.22 | 151.52 |
Alkem Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 3331.31 | 4236.38 | 4876.75 | 5473.34 | 5695.11 | 6806.75 | 7710.98 | 9390.6 | 9063.11 | 10125.02 | |
PROFIT | 337.54 | 709.35 | 884.57 | 715.41 | 801.27 | 1261.35 | 1668.59 | 1539.43 | 1144.71 | 1802.01 | |
EPS | 30.02 | 58.57 | 73.87 | 59.88 | 66.9 | 105.76 | 140.95 | 128.92 | 94.9 | 146.14 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
Reserves Total | 10,288.15 | 9,021.38 | 8,613.99 | 7,352.82 | 6,136.76 | 5,415.43 | 4,839.86 | 4,443.73 | 3,668.05 | 2,975.14 |
Total Shareholders Funds | 10,312.06 | 9,045.29 | 8,637.9 | 7,376.73 | 6,160.67 | 5,439.34 | 4,863.77 | 4,467.64 | 3,691.96 | 2,999.05 |
Minority Interest | 402.34 | 389.71 | 209.43 | 181.28 | 148.3 | 132.61 | 121.55 | 115.23 | 95.02 | 85.65 |
Secured Loans | 428.76 | 300.57 | 1,335.32 | 686.3 | 634.43 | 459.27 | 552.14 | 387.15 | 376.59 | 942.34 |
Unsecured Loans | 989.65 | 1,096.11 | 1,332.87 | 1,105.68 | 981.09 | 484.8 | 445.42 | 272.31 | 280.91 | 363.58 |
Total Debt | 1,418.41 | 1,396.68 | 2,668.19 | 1,791.98 | 1,615.52 | 944.07 | 997.56 | 659.46 | 657.5 | 1,305.92 |
Other Liabilities | 636.69 | 544.17 | 340.67 | 259.56 | 318.08 | 187.11 | 164.6 | 113.46 | 85.61 | 75.3 |
Total Liabilities | 12,769.5 | 11,375.85 | 11,856.19 | 9,609.55 | 8,242.57 | 6,703.13 | 6,147.48 | 5,355.79 | 4,530.09 | 4,465.92 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 4,543.71 | 4,050.26 | 4,185.6 | 3,768.85 | 3,606.95 | 3,026.09 | 2,603.78 | 1,977.2 | 1,538.64 | 1,744.89 |
Less: Accumulated Depreciation | 1,670.93 | 1,367.41 | 1,283.87 | 975.87 | 698.94 | 495.65 | 320.19 | 180.16 | 89.1 | 370.55 |
Net Block | 2,872.78 | 2,682.85 | 2,901.73 | 2,792.98 | 2,908.01 | 2,530.44 | 2,283.59 | 1,797.04 | 1,449.54 | 1,374.34 |
Capital Work in Progress | 158.57 | 323.24 | 339.48 | 393.28 | 362.97 | 492.96 | 380.97 | 299.26 | 172.42 | 110.69 |
Investments | 483.79 | 621.82 | 370.98 | 332.78 | 261.39 | 323.62 | 444.27 | 553 | 508.57 | 480.78 |
Inventories | 2,661.18 | 2,607.53 | 3,005.53 | 2,312.44 | 1,818.82 | 1,499.87 | 1,442.19 | 1,206 | 909.37 | 784.23 |
Sundry Debtors | 2,252.81 | 2,132.18 | 1,884.6 | 1,607.21 | 1,649.36 | 1,248.41 | 1,080.5 | 713.64 | 567.51 | 527.08 |
Cash and Bank Balance | 1,579.35 | 2,616.89 | 2,578.58 | 1,990.45 | 1,092.21 | 661.6 | 576.78 | 399.26 | 780.9 | 790.76 |
Loans and Advances | 3,769.25 | 1,055.87 | 827.41 | 834.34 | 775.37 | 578.37 | 567.93 | 304.68 | 236.74 | 174.93 |
Total Current Assets | 10,262.59 | 8,412.47 | 8,296.12 | 6,744.44 | 5,335.76 | 3,988.25 | 3,667.4 | 2,623.58 | 2,494.52 | 2,277 |
Current Liabilities | 2,623.54 | 1,984.61 | 1,923.08 | 1,654.14 | 1,471.42 | 1,348.83 | 1,375.19 | 1,075.09 | 876.62 | 649.07 |
Provisions | 181.86 | 396.19 | 289.92 | 255.57 | 231.55 | 155.93 | 141.29 | 136.7 | 126.94 | 84.42 |
Total Current Liabilities & Provisions | 2,805.4 | 2,380.8 | 2,213 | 1,909.71 | 1,702.97 | 1,504.76 | 1,516.48 | 1,211.79 | 1,003.56 | 733.49 |
Net Current Assets | 7,457.19 | 6,031.67 | 6,083.12 | 4,834.73 | 3,632.79 | 2,483.49 | 2,150.92 | 1,411.79 | 1,490.96 | 1,543.51 |
Deferred Tax Assets | 1,770.42 | 1,498.3 | 1,527.92 | 1,281.97 | 1,099.99 | 1,066.13 | 965.33 | 894.16 | 666.32 | 33.68 |
Deferred Tax Liability | 255.59 | 195.8 | 218.66 | 174.06 | 167.42 | 358.8 | 311.39 | 198.36 | 151.1 | 125.55 |
Net Deferred Tax | 1,514.83 | 1,302.5 | 1,309.26 | 1,107.91 | 932.57 | 707.33 | 653.94 | 695.8 | 515.22 | -91.87 |
Other Assets | 282.34 | 413.77 | 851.62 | 147.87 | 144.84 | 165.29 | 233.79 | 598.9 | 393.38 | 1,048.47 |
Total Assets | 12,769.5 | 11,375.85 | 11,856.19 | 9,609.55 | 8,242.57 | 6,703.13 | 6,147.48 | 5,355.79 | 4,530.09 | 4,465.92 |
Contingent Liabilities | 97.72 | 323.79 | 307.47 | 296.33 | 280.91 | 330.58 | 276.75 | 312.33 | 325.62 | 263.06 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
Reserves Total | 10,530.7 | 9,325.94 | 8,719.75 | 7,601.84 | 6,256.53 | 5,441.3 | 4,861.45 | 4,368.74 | 3,575.59 | 3,077.11 |
Total Shareholders Funds | 10,554.61 | 9,349.85 | 8,743.66 | 7,625.75 | 6,280.44 | 5,465.21 | 4,885.36 | 4,392.65 | 3,599.5 | 3,101.02 |
Secured Loans | 172.02 | 119.31 | 1,010.07 | 327.88 | 238.6 | 32.38 | 110.71 | 108 | 151.06 | 883.24 |
Unsecured Loans | 833.19 | 1,062.38 | 1,283.71 | 1,055.63 | 970.78 | 470.58 | 436.81 | 260.23 | 229.21 | 219.3 |
Total Debt | 1,005.21 | 1,181.69 | 2,293.78 | 1,383.51 | 1,209.38 | 502.96 | 547.52 | 368.23 | 380.27 | 1,102.54 |
Other Liabilities | 339.19 | 291.48 | 263.91 | 197.35 | 239.31 | 150.75 | 135.8 | 92.35 | 68.62 | 60.09 |
Total Liabilities | 11,899.01 | 10,823.02 | 11,301.35 | 9,206.61 | 7,729.13 | 6,118.92 | 5,568.68 | 4,853.23 | 4,048.39 | 4,263.65 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 3,144.31 | 2,932.25 | 2,826.98 | 2,481.89 | 2,351.73 | 1,973.17 | 1,713.69 | 1,262.9 | 944.72 | 1,156.17 |
Less : Accumulated Depreciation | 1,362.07 | 1,107.16 | 944.91 | 723.53 | 514.97 | 366.79 | 242.7 | 137.27 | 70.04 | 285.71 |
Net Block | 1,782.24 | 1,825.09 | 1,882.07 | 1,758.36 | 1,836.76 | 1,606.38 | 1,470.99 | 1,125.63 | 874.68 | 870.46 |
Capital Work in Progress | 90.78 | 228.75 | 232.45 | 323.26 | 313.66 | 381.59 | 298.92 | 218.44 | 146.55 | 95.89 |
Investments | 2,828.98 | 3,005.55 | 2,528.61 | 2,152.38 | 1,956.04 | 1,695.6 | 1,544.5 | 1,517.64 | 1,157.67 | 1,070.56 |
Inventories | 1,849.56 | 1,724.66 | 1,975.73 | 1,513.26 | 1,092.58 | 991.28 | 1,024.16 | 858.76 | 590.03 | 548.24 |
Sundry Debtors | 1,753.64 | 1,768.34 | 1,768.22 | 1,556.55 | 1,555.07 | 966.64 | 875 | 633.32 | 480.44 | 375.01 |
Cash and Bank Balance | 1,065.85 | 2,163.87 | 2,297.21 | 1,673.36 | 765.61 | 397.94 | 278.3 | 199.06 | 524.03 | 633.32 |
Loans and Advances | 3,227.27 | 802.75 | 684.29 | 726.2 | 654.4 | 505.64 | 513.15 | 284.89 | 211.98 | 160.81 |
Total Current Assets | 7,896.32 | 6,459.62 | 6,725.45 | 5,469.37 | 4,067.66 | 2,861.5 | 2,690.61 | 1,976.03 | 1,806.48 | 1,717.38 |
Current Liabilities | 2,028.15 | 1,683.76 | 1,673.8 | 1,367.46 | 1,207.97 | 1,041.45 | 1,143.03 | 941.16 | 684.39 | 461.99 |
Provisions | 110.64 | 224.44 | 194.02 | 198.66 | 168.73 | 131.78 | 102.46 | 103.96 | 89.63 | 66.65 |
Total Current Liabilities & Provisions | 2,138.79 | 1,908.2 | 1,867.82 | 1,566.12 | 1,376.7 | 1,173.23 | 1,245.49 | 1,045.12 | 774.02 | 528.64 |
Net Current Assets | 5,757.53 | 4,551.42 | 4,857.63 | 3,903.25 | 2,690.96 | 1,688.27 | 1,445.12 | 930.91 | 1,032.46 | 1,188.74 |
Deferred Tax Assets | 1,540.21 | 1,292.74 | 1,248.66 | 1,143.51 | 1,005.92 | 835.63 | 759.87 | 753.12 | 555.95 | 29.2 |
Deferred Tax Liability | 253.55 | 207.82 | 199.92 | 189.08 | 186.76 | 199.04 | 181.82 | 162.12 | 146.56 | 97.71 |
Net Deferred Tax | 1,286.66 | 1,084.92 | 1,048.74 | 954.43 | 819.16 | 636.59 | 578.05 | 591 | 409.39 | -68.51 |
Other Assets | 152.82 | 127.29 | 751.85 | 114.93 | 112.55 | 110.49 | 231.1 | 469.61 | 427.64 | 1,106.51 |
Total Assets | 11,899.01 | 10,823.02 | 11,301.35 | 9,206.61 | 7,729.13 | 6,118.92 | 5,568.68 | 4,853.23 | 4,048.39 | 4,263.65 |
Contingent Liabilities | 100.88 | 289.52 | 274.92 | 287.75 | 278.73 | 329.43 | 277.3 | 310.82 | 684.87 | 354.94 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 2,023.13 |
Depreciation | 299.3 |
Interest (Net) | -163.36 |
Dividend Received | 0.19 |
P/L on Sales of Assets | 3.18 |
P/L on Sales of Invest | -14.63 |
Prov. and W/O (Net) | 181.44 |
P/L in Forex | 58.89 |
Total Adjustments (PBT and Ext... | 383.57 |
Operating Profit before Workin... | 2,406.7 |
Trade and 0ther Receivables | -221.99 |
Inventories | -73.4 |
Trade Payables | 525.28 |
Loans and Advances | -135.11 |
Total Adjustments (OP before W... | -51.69 |
Cash Generated from/(used in) ... | 2,355.01 |
Direct Taxes Paid | -406.94 |
Total Adjustments(Cash Generat... | -406.94 |
Cash Flow before Extraordinary... | 1,948.07 |
Net Cash from Operating Activi... | 1,948.07 |
Purchased of Fixed Assets | -259.29 |
Sale of Fixed Assets | 72.48 |
Purchase of Investments | -53.37 |
Interest Received | 239.28 |
Net Cash used in Investing Act... | -1,010.55 |
Proceed from 0ther Long Term B... | 40 |
Of the Short Term Borrowings | -520.89 |
Of Financial Liabilities | -32.32 |
Dividend Paid | -540.49 |
Interest Paid | -91.31 |
Net Cash used in Financing Act... | -1,145.01 |
Net Profit before Tax and Extr... | 1,881.03 |
Depreciation | 244.35 |
Interest (Net) | -145.56 |
Dividend Received | 2.61 |
P/L on Sales of Assets | 2.84 |
P/L on Sales of Invest | -13.96 |
Prov. and W/O (Net) | 91.24 |
P/L in Forex | 38.2 |
Total Adjustments (PBT and Ext... | 211.74 |
Operating Profit before Workin... | 2,092.77 |
Trade and 0ther Receivables | -43.75 |
Inventories | -124.91 |
Trade Payables | 355.24 |
Loans and Advances | -69.61 |
Total Adjustments (OP before W... | -53.38 |
Cash Generated from/(used in) ... | 2,039.39 |
Direct Taxes Paid | -352.83 |
Total Adjustments(Cash Generat... | -352.83 |
Cash Flow before Extraordinary... | 1,686.56 |
Net Cash from Operating Activi... | 1,686.56 |
Purchased of Fixed Assets | -106.68 |
Sale of Fixed Assets | 6.24 |
Purchase of Investments | -18.9 |
Interest Received | 190.97 |
Net Cash used in Investing Act... | -865.6 |
Of the Short Term Borrowings | -344.37 |
Of Financial Liabilities | -14.51 |
Dividend Paid | -538.04 |
Interest Paid | -62.12 |
Net Cash used in Financing Act... | -959.04 |
Company Details
Registered Office |
|
Address | Alkem House SenapatiBapat Marg, Lower Parel |
City | Mumbai |
State | Maharashtra |
Pin Code | 400013 |
Tel. No. | 91-22-39829999 |
Fax. No. | 91-22-24952955 |
investors@alkem.com ; contact@alkem.com | |
Internet | http://www.alkemlabs.com |
Registrars |
|
Address | Alkem House SenapatiBapat Marg |
City | Mumbai |
State | Maharashtra |
Pin Code | 400013 |
Tel. No. | 91-22-39829999 |
Fax. No. | 91-22-24952955 |
investors@alkem.com ; contact@alkem.com | |
Internet | http://www.alkemlabs.com |
Management |
|
Name | Designation |
Basudeo N Singh | Executive Chairman |
SANDEEP SINGH | Managing Director |
Mritunjay Kumar Singh | Executive Director |
A K Purwar | Non-Exec. & Independent Dir. |
SANGEETA KAPILJIT SINGH | Non-Exec. & Independent Dir. |
SUDHA RAVI | Non-Exec. & Independent Dir. |
Manish Narang | Company Sec. & Compli. Officer |
Narendra Aneja | Non-Exec. & Independent Dir. |
SARVESH SINGH | Executive Director |
Madhurima Singh | Executive Director |
Sujjain Talwar | Independent Director |
Srinivas Singh | Executive Director |